SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-032621
Filing Date
2014-02-03
Accepted
2014-02-03 13:46:05
Documents
3
Period of Report
2014-01-31
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d668486d8k.htm 8-K 20494
2 EX-99.1 d668486dex991.htm EX-99.1 8460
3 GRAPHIC g668486image1.jpg GRAPHIC 6399
  Complete submission text file 0001193125-14-032621.txt   39179
Mailing Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121 2062827100
CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12465 | Film No.: 14567525
SIC: 2834 Pharmaceutical Preparations